Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11419865 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL7618850 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL22406167 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL299921 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL10887320 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL2198710 | 0.91 | — | — | |
| SCHEMBL31462481 | 0.84 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL31157781 | 0.84 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL31462477 | 0.84 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL23510269 | 0.81 | TXN (0.31) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552997-B2 | Targeted disulfide reduction in petroleum matrices | CHEVRON U.S.A. INC. (US) | 2026-02-17 | — | — | US | claimed |
| US-7202235-B2 | Tetracycline compounds for treatment of cryptosporidium parvum related disorders | TRUSTEES OF TUFTS COLLEGE (US) | 2007-04-10 | — | — | US | claimed |
| US-20050215532-A1 | Tetracycline compounds for treatment of cryptosporidium parvum related disorders | TRUSTEES OF TUFTS COLLEGE (US) | 2005-09-29 | — | — | US | claimed |
| EP-1263442-A1 | TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS | TRUSTEES OF TUFTS COLLEGE (US) | 2002-12-11 | — | — | EP | claimed |
| US-20020115644-A1 | Tetracycline compounds for treatment of Cryptosporidium parvum related disorders | PARATEK PHARMACEUTICALS, INC. | 2002-08-22 | — | — | US | claimed |
| WO-2001052858-A1 | TETRACYCLINE COMPOUNDS FOR TREATMENT OF CRYPTOSPORIDIUM PARVUM RELATED DISORDERS | TRUSTEES OF TUFTS COLLEGE (US) | 2001-07-26 | — | — | WO | claimed |
| CN-121574079-A | Method for synthesizing dithioalkyl ketone compound by using diisopropylamine | 苏州大学 | 2026-02-27 | — | — | CN | disclosed |
| US-12552997-B2 | Targeted disulfide reduction in petroleum matrices | CHEVRON U.S.A. INC. (US) | 2026-02-17 | — | — | US | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| CN-118271233-A | Nilaparil manufacturing method | 特沙诺有限公司 | 2024-07-02 | — | — | CN | disclosed |
| WO-2024097698-A1 | TARGETED DISULFIDE REDUCTION IN PETROLEUM MATRICES | CHEVRON U.S.A. INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20240141238-A1 | Targeted Disulfide Reduction in Petroleum Matrices | CHEVRON U.S.A. INC. | 2024-05-02 | — | — | US | disclosed |
| WO-1984004092-A1 | (HYDROCARBYLTHIO)PHENOLS AND THEIR PREPARATION | ETHYL CORP (US) | 1984-10-25 | — | — | WO | disclosed |
| EP-0122203-A1 | (Hydrocarbylthio)phenols and their preparation | ETHYL CORPORATION (US) | 1984-10-17 | — | — | EP | disclosed |
| US-4324920-A | REACTION OF A PHENOL WITH A HYDROCARBYL DISULFIDE IN THE PRESENCE OF AN ALUMINUM PHENOXIDE | ETHYL CORPORATION (US) | 1982-04-13 | — | — | US | disclosed |
| US-4219393-A | ELECTROLYTIC OXIDATION | OUCHI SHINKO KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1980-08-26 | — | — | US | disclosed |
| US-4133830-A | RECYCLING BY-PRODUCTS TO SUCCESSIVE RUNS TO IMPROVE YIELD | STAUFFER CHEMICAL COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4000190-A | FROM DIALKYL OR DIARYL DISULFIDES, PHOSPHORUS, AND PHOSPHORUS TRIHALIDE | STAUFFER CHEMICAL COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3971820-A | TETRAMIZATION OF HALOGEN CYANIDE, BASIC CATALYST | NIPPON SODA COMPANY LIMITED (JA) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115644-A1 | Tetracycline compounds for treatment of Cryptosporidium parvum related disorders | TUBA1C, TUBB6, TUBB1 | ALDH1A1 4471/4885THRB 331/4885MEN1 3438/4885 |
| US-12552997-B2 | Targeted disulfide reduction in petroleum matrices | DDHD2, ATP2A2, ORAI1 | ALDH1A1 584/4885THRB 4036/4885MEN1 3714/4885 |
| US-20050215532-A1 | Tetracycline compounds for treatment of cryptosporidium parvum related disorders | TUBA1C, TUBB6, TUBB1 | ALDH1A1 4471/4885THRB 331/4885MEN1 3438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.